Fundraising Fox

Eclipse Bio

San Diego, US · Founded 2017 · Delaware corporation · 4 known investors

eclipsebio.com ↗

Eclipsebio provides RNA biology expertise and analytical technologies for drug developers and researchers, offering AI-powered sequence design, nucleotide-level characterization, and sequencing-based assays across small oligonucleotides, small molecules targeting RNA, AI training data, and basic research applications.

AI & Machine LearningBiotechDeep Techin /eclipse-bioinnovations

Founders & leadership

PC
Peter ChuExecutive Officer, Director
DV
Daniel VasellaDirector
EW
Edmond WongDirector
EY
Eugene YeoDirector
EL
Eric L Van NostrandDirector
HK
Hallie KuhnDirector

Investors · 4

Brainstorm VenturesSan Francisco
iGlobe PartnersSingapore · $600K – $6M
Magnetic VenturesBoston · $1M – $6M
Phoenix Venture PartnersSan Mateo · $100K – $3M

Reported raises · per SEC filings

Form D private placements
▶$4.9MraisedNov 2025 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter ChuExecutive Officer, Director
  • Daniel VasellaDirector
  • Edmond WongDirector
  • Eugene YeoDirector
Offering amount
$7.2M
Amount sold
$4.9M
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedSep 2021 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel VasellaDirector
  • Peter ChuExecutive Officer, Director
  • Eric L Van NostrandDirector
  • Hallie KuhnDirector
  • Eugene W YeoDirector
Offering amount
$15M
Amount sold
$12M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news